VIGONVITA-B Maintains Unchanged Share Base and Public-Float Compliance in May 2026 Update

Bulletin Express06-04

Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has filed its Monthly Return on Movements in Securities for the period ended 31 May 2026 with Hong Kong Exchanges and Clearing Limited, confirming a steady capital structure and full compliance with public-float rules.

The company’s authorised share capital remained at 167.60 million ordinary shares with a par value of RMB1 each. This comprises: • 66.68 million H-shares listed in Hong Kong. • 100.92 million unlisted domestic shares.

Issued share capital was unchanged during the month: 66.68 million H-shares and 100.92 million unlisted shares, with no treasury shares outstanding. Vigonvita also affirmed that its H-share public float comfortably meets the Main Board’s minimum 25% requirement.

No share options, warrants, convertible securities or other equity-linked instruments were issued, exercised or cancelled in May, and there were no repurchases or other share movements. The company reported no Hong Kong Depositary Receipts.

All requisite confirmations—including receipt of all consideration, fulfilment of listing conditions and regulatory filings—were provided by Board Secretary and Joint Company Secretary Guo Ting in the 4 June 2026 submission.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1152862710?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152862710","market":"hk","top_or_hot":-1,"title":"VIGONVITA-B Maintains Unchanged Share Base and Public-Float Compliance in May 2026 Update","media":"Bulletin Express","content":"<p>Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has filed its Monthly Return on Movements in Securities for the period ended 31 May 2026 with Hong Kong Exchanges and Clearing Limited, confirming a steady capital structure and full compliance with public-float rules.</p>\n<p>The company’s authorised share capital remained at 167.60 million ordinary shares with a par value of RMB1 each. This comprises:\n• 66.68 million H-shares listed in Hong Kong.  \n• 100.92 million unlisted domestic shares.</p>\n<p>Issued share capital was unchanged during the month: 66.68 million H-shares and 100.92 million unlisted shares, with no treasury shares outstanding. Vigonvita also affirmed that its H-share public float comfortably meets the Main Board’s minimum 25% requirement.</p>\n<p>No share options, warrants, convertible securities or other equity-linked instruments were issued, exercised or cancelled in May, and there were no repurchases or other share movements. The company reported no Hong Kong Depositary Receipts.</p>\n<p>All requisite confirmations—including receipt of all consideration, fulfilment of listing conditions and regulatory filings—were provided by Board Secretary and Joint Company Secretary Guo Ting in the 4 June 2026 submission.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>VIGONVITA-B Maintains Unchanged Share Base and Public-Float Compliance in May 2026 Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVIGONVITA-B Maintains Unchanged Share Base and Public-Float Compliance in May 2026 Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-04 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has filed its Monthly Return on Movements in Securities for the period ended 31 May 2026 with Hong Kong Exchanges and Clearing Limited, confirming a steady capital structure and full compliance with public-float rules.</p>\n<p>The company’s authorised share capital remained at 167.60 million ordinary shares with a par value of RMB1 each. This comprises:\n• 66.68 million H-shares listed in Hong Kong.  \n• 100.92 million unlisted domestic shares.</p>\n<p>Issued share capital was unchanged during the month: 66.68 million H-shares and 100.92 million unlisted shares, with no treasury shares outstanding. Vigonvita also affirmed that its H-share public float comfortably meets the Main Board’s minimum 25% requirement.</p>\n<p>No share options, warrants, convertible securities or other equity-linked instruments were issued, exercised or cancelled in May, and there were no repurchases or other share movements. The company reported no Hong Kong Depositary Receipts.</p>\n<p>All requisite confirmations—including receipt of all consideration, fulfilment of listing conditions and regulatory filings—were provided by Board Secretary and Joint Company Secretary Guo Ting in the 4 June 2026 submission.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02630","symbol_name":"旺山旺水-B","start_time":0,"source_url":"","article_id":"1152862710","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152862710","pubTimestamp":1780565109,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has filed its Monthly Return on Movements in Securities for the period ended 31 May 2026 with Hong Kong Exchanges and Clearing Limited, confirming a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02630":"旺山旺水-B"},"translate_title":"VIGONVITA-B在2026年5月更新中保持股份基础和公众持股合规性不变","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02630":1},"content_text":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has filed its Monthly Return on Movements in Securities for the period ended 31 May 2026 with Hong Kong Exchanges and Clearing Limited, confirming a steady capital structure and full compliance with public-float rules.\nThe company’s authorised share capital remained at 167.60 million ordinary shares with a par value of RMB1 each. This comprises:\n• 66.68 million H-shares listed in Hong Kong.  \n• 100.92 million unlisted domestic shares.\nIssued share capital was unchanged during the month: 66.68 million H-shares and 100.92 million unlisted shares, with no treasury shares outstanding. Vigonvita also affirmed that its H-share public float comfortably meets the Main Board’s minimum 25% requirement.\nNo share options, warrants, convertible securities or other equity-linked instruments were issued, exercised or cancelled in May, and there were no repurchases or other share movements. The company reported no Hong Kong Depositary Receipts.\nAll requisite confirmations—including receipt of all consideration, fulfilment of listing conditions and regulatory filings—were provided by Board Secretary and Joint Company Secretary Guo Ting in the 4 June 2026 submission.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1152862710","isCrawlerRequest":true}